Search Tag: cardio-kidney-metabolic conditions

2024 01 Sep

  A pooled analysis of three major trials presented at #ESCCongress2024  did not show significant reductions in cardiovascular death with finerenone. However, significant decreases in all-cause mortality, cardiovascular events, and kidney outcomes were observed.    Cardiovascular diseases, chronic kidney disease (CKD), and metabolic conditions...Read more